MENU
AGIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Agios Pharmaceuticals (AGIO) Ownership - Who owns Agios Pharmaceuticals?
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.84B
P/E Ratio
2.76
Total Cash
893.38M
Projected Growth
N/A
Total Debt
52.94M
Revenue
37.04M
Risk (Beta)
0.75
Dividend Yield
N/A
Total Cash/Share
15.43
Total Debt/Equity
N/A
Revenue/Share
0.64 USD as % of share price
Fundamentals
AGIO
Capitalization
1.84B
P/E Ratio
2.76
Risk (Beta)
0.75
Dividend Yield
N/A
Total Cash
893M
Total Cash/Share
15.43
Total Debt
52.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.64%
Revenue
37M
ROE
N/A
Book Value
1.47B
P/B Ratio
1.26
Cash Flow
N/A
Earnings
11.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
74K
Current Ratio
18.50
Current Revenue Per Employee
17881.15
Dividends Per Share - Security
N/A
EBITDA
-434.71M
Float
N/A
Float - Current
N/A
Gross Income Margin
87.57
Revenue To Assets
55.38
Shares Held By Institutions
5.15B
Shares Outstanding - Current
57.9M
Total Liabilities
89M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-3.104
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com